Biocon Prepares For Life After Pfizer
This article was originally published in PharmAsia News
Executive Summary
Following the dissolution of its global biosimilars deal with Pfizer, Biocon Chairman Kiran Mazumdar-Shaw speaks with PharmAsia News about the path ahead.